This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Goodman, G., McLean, A., Alberts, D. et al. Inhibition of human tumour clonogenicity by chlorambucil and its metabolites. Br J Cancer 45, 621–623 (1982). https://doi.org/10.1038/bjc.1982.101
Issue Date:
DOI: https://doi.org/10.1038/bjc.1982.101
This article is cited by
-
Inter- and intraindividual differences in oral chlorambucil pharmacokinetics
European Journal of Clinical Pharmacology (1988)
-
Pharmacokinetic basis for the comparative antitumour activity and toxicity of chlorambucil, phenylacetic acid mustard and ?,?-difluorochlorambucil (CB 7103) in mice
Cancer Chemotherapy and Pharmacology (1986)
-
Effect of food on pharmacokinetics of chlorambucil and its main metabolite, phenylacetic acid mustard
European Journal of Clinical Pharmacology (1984)